This chemical selectively inhibits colony formation of CD34+ AML cells, but has no effect on normal CD34+ cells; fenretinide also reduces the in vivo engraftment of AML CD34+ cells, but has no effect on normal hematopoietic stem cells in non-obese diabetic SCID mice [95]. The gene discussed is CD34; the disease is acute myeloid leukemia.